Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
NT-I7 is a fusion protein comprised of a recombinant interleukin-7 (IL-7) linked to a hybrid immunoglobulin Fc region, which potentially has increased stability and enhances anti-tumor immune response (Journal of Clinical Oncology 37, no. 15_suppl, Abs nr: e13516).
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|Atezolizumab + NT-I7||Atezolizumab NT-I7||0||1|
|Dexamethasone + NT-I7||Dexamethasone NT-I7||0||1|
|NT-I7 + Radiotherapy + Temozolomide||NT-I7 Radiotherapy Temozolomide||0||1|